In this Friday’s PCT Grand Rounds, Saul Faust of the University of Southampton will present “The HARMONIE Trial: Reimagining How to Design and Deliver Contract Commercial Clinical Trials.”
The Grand Rounds session will be held on Friday, September 13, 2024, at 1:00 pm eastern.
The HARMONIE trial was a pragmatic trial of the effect of nirsevimab on hospitalizations for respiratory syncytial virus–associated lower respiratory tract infection when administered in healthy infants in France, Germany, and the United Kingdom.
Faust is a professor of pediatric immunology and infectious diseases at the University of Southampton, the director of the National Institute for Health Research (NIHR) Southampton Clinical Research Facility, the clinical director of the Wessex Local Clinical Research Network, and a NIHR senior investigator.